November 2022

News

Detecting of SARS CoV-2 in wastewater

A team of Japanese scientists have developed a simple, rapid, highly sensitive method for the detection of SARS-CoV-2 in wastewater.

Microbiology & Virology

News

Biopsy, diagnostics and tumour removal

Researchers from Japan may have devised a way to perform the initial biopsy, lab tests, and subsequent tumour removal during one surgical procedure.

Molecular Pathology & Genomics

Resources

My lab: specialist testing services

Phil Cummings, Training Manager, and Herbert Tsuro, Project Lead, give a guided tour of blood transfusion laboratories in Leeds.

Haematology & Transfusion Science

News

Data-driven learning health systems

Researchers are calling on policymakers to support the use of data-driven learning health systems to deliver a step change in the NHS’s ability to improve patient care.

Microbiology & Virology

Resources

Here to help: supporting school activities

How the IBMS can drive forward face-to-face public engagement in a post-pandemic world.

News

Skin susceptibility to diseases

Research from UC Davis Health explores how differences in skin composition may lead to dermatological conditions, such as psoriasis and atopic dermatitis.

Microbiology & Virology

News

Under the microscope: lecanemab

This month: lecanemab

Immunology

Science

Three placements

Elesha George, a fourth-year student at Aberdeen’s Robert Gordon University, talks through a year of very different placements.

Haematology & Transfusion Science

News

Cell-free DNA cancer detection

A US-led research team has reported successful results from an experimental cell-free DNA (cfDNA) cancer-detection system that is claimed to be cost effective.

Molecular Pathology & Genomics

News

Has the pandemic changed our personalities?

The COVID-19 pandemic may have altered the trajectory of personality across the US – especially in younger adults – according to a new study.

Immunology

News

Making tissue engineering a reality

A team led by tissue-engineering pioneer and biologist Arnold Caplan aims to close the gap between academic promise and clinical and commercial reality in the still-nascent science of generating new bodily tissues.